JP2024525843A5 - - Google Patents
Info
- Publication number
- JP2024525843A5 JP2024525843A5 JP2024502438A JP2024502438A JP2024525843A5 JP 2024525843 A5 JP2024525843 A5 JP 2024525843A5 JP 2024502438 A JP2024502438 A JP 2024502438A JP 2024502438 A JP2024502438 A JP 2024502438A JP 2024525843 A5 JP2024525843 A5 JP 2024525843A5
- Authority
- JP
- Japan
- Prior art keywords
- glu
- lys
- pharmaceutically acceptable
- acceptable salt
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163222747P | 2021-07-16 | 2021-07-16 | |
| US63/222,747 | 2021-07-16 | ||
| PCT/US2022/073793 WO2023288313A1 (en) | 2021-07-16 | 2022-07-15 | Compositions including multi-agonist peptides and methods of manufacture and use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024525843A JP2024525843A (ja) | 2024-07-12 |
| JP2024525843A5 true JP2024525843A5 (https=) | 2025-07-24 |
Family
ID=84919777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502438A Pending JP2024525843A (ja) | 2021-07-16 | 2022-07-15 | マルチアゴニストペプチドを含む組成物並びに製造及び使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230203100A1 (https=) |
| EP (1) | EP4370537A4 (https=) |
| JP (1) | JP2024525843A (https=) |
| AU (1) | AU2022311018A1 (https=) |
| CA (1) | CA3226003A1 (https=) |
| WO (1) | WO2023288313A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL322661A (en) * | 2023-02-10 | 2025-10-01 | Hangzhou Sciwind Biosciences Co Ltd | Polypeptide and its history, composition containing them and their use |
| TW202540155A (zh) | 2023-11-30 | 2025-10-16 | 丹麥商諾佛 儂迪克股份有限公司 | Glp-1、gip及澱粉素受體之三重促效劑 |
| EP4582441A3 (en) * | 2023-12-12 | 2025-09-10 | Amide Technologies | Multimeric polypeptides and uses thereof |
| TW202600132A (zh) | 2024-03-08 | 2026-01-01 | 美商安尼波那生物公司 | 用於治療肥胖症及提高減重之方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070115947A (ko) * | 2005-02-11 | 2007-12-06 | 아밀린 파마슈티칼스, 인크. | 선택가능한 특성들을 가지는 ｇｉｐ 유사체 및 하이브리드폴리펩타이드 |
| US8598314B2 (en) * | 2007-09-27 | 2013-12-03 | Amylin Pharmaceuticals, Llc | Peptide-peptidase-inhibitor conjugates and methods of making and using same |
| PE20150863A1 (es) * | 2012-06-21 | 2015-06-11 | Univ Indiana Res & Tech Corp | Analogos de glucagon que exhiben actividad de receptor de gip |
| US12122815B2 (en) * | 2018-09-24 | 2024-10-22 | Takeda Pharmaceutical Company Limited | GIP receptor agonist peptide compounds and uses thereof |
| CN115916812A (zh) * | 2020-03-25 | 2023-04-04 | 武田药品工业株式会社 | Gip受体激动剂肽化合物及其用途 |
-
2022
- 2022-07-15 JP JP2024502438A patent/JP2024525843A/ja active Pending
- 2022-07-15 AU AU2022311018A patent/AU2022311018A1/en active Pending
- 2022-07-15 WO PCT/US2022/073793 patent/WO2023288313A1/en not_active Ceased
- 2022-07-15 CA CA3226003A patent/CA3226003A1/en active Pending
- 2022-07-15 EP EP22843079.9A patent/EP4370537A4/en active Pending
- 2022-07-15 US US17/812,993 patent/US20230203100A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525843A5 (https=) | ||
| TWI811236B (zh) | B型肝炎抗病毒試劑 | |
| RU2006109187A (ru) | Агонисты рецептора меланокортина | |
| JP2023078367A5 (https=) | ||
| JP2023530515A5 (https=) | ||
| JP2013517307A5 (https=) | ||
| JP2013523618A5 (https=) | ||
| CN109925312A (zh) | 用于治疗眼病的组合物、制剂和方法 | |
| IL287470B1 (en) | Derivatives of 6-methyl-6,1-dihydro-7H-pyrrolo[3,2-c]pyridin-7-one or of an acceptable pharmaceutical salt thereof and pharmaceutical preparations containing them. | |
| JP2022504596A5 (https=) | ||
| EP0456758A1 (en) | Anaphylatoxin-receptor ligands | |
| JP2022543826A5 (https=) | ||
| CN115368438A (zh) | 吡咯烷酰胺衍生物及其制备和使用方法 | |
| CA3211494A1 (en) | Protein-drug conjugates for antiviral therapy | |
| JP2023533162A5 (https=) | ||
| KR20120125610A (ko) | 시클로스포린 유사체 | |
| CN105348345A (zh) | 一种含有硫普罗宁结构的前药、其制备方法、药物组合物及其用途 | |
| WO2023086028A2 (en) | Allenamide linkers for antibody-drug conjugate | |
| JP2022520410A5 (https=) | ||
| WO2000054808A1 (fr) | Agoniste du recepteur ep4 de la prostaglandine et traitement correspondant | |
| JP2022501364A5 (https=) | ||
| JP2023537895A5 (https=) | ||
| US6426330B1 (en) | Satiety inducing composition comprising Neuropeptide Y analogues and methods of inducing satiety and treating a disease or condition associated with it | |
| JP2023524274A5 (https=) | ||
| JP2022521474A5 (https=) |